Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

SOP for Refractive Index Testing

Posted on By

SOP for Refractive Index Testing

Procedure for Refractive Index Testing

1) Purpose

The purpose of this SOP is to outline the procedure for determining the refractive index of pharmaceutical liquids using appropriate analytical techniques.

2) Scope

This SOP applies to all pharmaceutical liquids within the facility that require refractive index testing as part of quality control, following pharmacopeial guidelines and internal specifications.

3) Responsibilities

Quality Control (QC) Department: Responsible for performing refractive index testing and ensuring compliance with this SOP.
Analytical Laboratory: Responsible for conducting analysis using suitable techniques and interpreting results accurately.

4) Procedure

4.1 Instrument Preparation:
    4.1.1 Ensure the refractometer is calibrated according to manufacturer instructions and method validation protocols.
    4.1.2 Verify the cleanliness and condition of the instrument prism and sample chamber.
    4.1.3 Stabilize the instrument at the specified temperature for accurate measurements.

See also  SOP for Particulate Matter Testing in Liquids

4.2 Sample Handling:
    4.2.1 Obtain representative samples of pharmaceutical liquids requiring refractive index analysis.
    4.2.2 Label samples with batch numbers, dates, and any other relevant information.
    4.2.3 Ensure samples are at the specified temperature for analysis to minimize temperature-related errors.

4.3 Measurement Procedure:
    4.3.1 Place a drop of the sample on the refractometer prism and close the cover gently to avoid air bubbles.
    4.3.2 Allow sufficient time for the sample to equilibrate with the prism

temperature and achieve stable readings.
    4.3.3 Record the refractive index value displayed on the instrument, ensuring accurate reading and notation of any adjustments.

4.4 Calibration Verification:
    4.4.1 Periodically verify the accuracy of the refractometer by measuring certified reference standards with known refractive indices.
    4.4.2 Document calibration verification results and adjust instrument settings if deviations are observed.
    4.4.3 Maintain records of calibration checks to ensure ongoing accuracy and traceability.

See also  SOP for Extrudability Testing in Ointments

4.5 Calculation and Documentation:
    4.5.1 Calculate and report the average refractive index value based on repeated measurements.
    4.5.2 Document all refractive index testing procedures, instrument settings, and results in the Refractive Index Testing Report.
    4.5.3 Review and approve the documentation by QC Manager before releasing results.

5) Abbreviations, if any

QC: Quality Control

6) Documents, if any

Refractive Index Testing Report
Instrument Calibration Records
Method Validation Protocol and Report

7) Reference, if any

USP General Chapter <831> – Refractive Index
Pharmacopeial standards for refractive index determination in pharmaceutical liquids

8) SOP Version

Version 1.0

In-Process Control Tags:Blend uniformity testing SOP, Bulk density testing SOP, Capsule content uniformity SOP, Capsule disintegration testing SOP, Capsule dissolution testing SOP, Capsule weight variation SOP, Clarity and opalescence testing of liquids SOP, Endotoxin testing in injectable products SOP, Flowability testing of powders SOP, Granulation size distribution SOP, Moisture content determination in granules SOP, Osmolality testing SOP, Particulate matter testing in liquids SOP, pH measurement of solutions SOP, Pyrogen testing SOP, Specific gravity testing of liquids SOP, Sterility testing SOP, Tablet disintegration testing SOP, Tablet dissolution testing SOP, Tablet friability testing SOP, Tablet hardness testing SOP, Tablet thickness measurement SOP, Tablet weight variation SOP, Uniformity of dosage units SOP, Viscosity testing of liquids SOP

Post navigation

Previous Post: SOP for Melting Point Determination
Next Post: Injectables: SOP for Handling of Deviations

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version